An urgent warning has been issued over a common menopause drug for its potentially fatal ... however it is only available on private prescription, costing around £75 for a month's supply.

The FDA submission is for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause ... in 14 countries worldwide. Both drugs are being positioned as alternatives ...

An experimental menopause drug from Bayer succeeded in a late-stage trial in women taking drugs to treat or prevent breast cancer, the company said Thursday. Bayer said the drug, elinzanetant ...

The drug’s mechanism is similar to that of its main competitor, Veozah, which targets the NK3 protein. Veozah is approved to treat symptoms of menopause and is also in Phase 3 testing in women ...

broadening the use case for the menopause treatment expected to launch as early as this year. The German company’s drug met all the goals of a late-stage study for the treatment of moderate to ...

Supermarket claims its new online clinic makes it much easier to order prescriptions for health and lifestyle conditions, ...

(Bloomberg) -- Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the use case for the menopause treatment expected to launch as ...